| Dr Robert Stephen Nierzwicki, MD | |
|
25 N Winfield Rd, Winfield, IL 60190-1295 | |
| (630) 232-0280 | |
| (630) 232-3895 |
| Full Name | Dr Robert Stephen Nierzwicki |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 18 Years |
| Location | 25 N Winfield Rd, Winfield, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194985564 | NPI | - | NPPES |
| 036123450 | Medicaid | IL | |
| 206147 | Other | IL | MEDICARE PTAN (GROUP) |
| 206147125 | Other | IL | MEDICARE PTAN (INDIVIDUAL) |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 036123450 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Dupage Hospital | Winfield, IL | Hospital |
| Delnor Community Hospital | Geneva, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Dupage Physician Group | 5890696231 | 1003 |
News Archive
A surgical procedure recommended to reduce the future risk of ovarian cancer has been successfully implemented throughout Kaiser Permanente in Northern California without a change in surgical outcomes, according to research published today in the journal Obstetrics & Gynecology.
OHSU physicians and researchers are developing what they hope will be the first permanent total artificial heart, which could provide the approximately 75,000 Americans who die of heart failure every year another chance at life.
The medication tilarginine, a drug that was believed could be beneficial for patients who develop cardiogenic shock (low blood pressure due to impaired cardiac function) after a heart attack, did not reduce the risk of death up to six months after a heart attack, according to a JAMA study published online March 26.
Michigan State University scientists are engineering a virus-like particle, known as Qβ, that will generate anti-cancer immune responses in the body and potentially be used as a new vaccine for the treatment of cancer.
Eligible fully vaccinated passengers arriving in England from countries not on the UK's red list can take a cheaper lateral flow test instead of a PCR from today [Sunday 24 October].
› Verified 4 days ago
| Entity Name | Central Dupage Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003864810 PECOS PAC ID: 0941108666 Enrollment ID: O20031231000723 |
News Archive
A surgical procedure recommended to reduce the future risk of ovarian cancer has been successfully implemented throughout Kaiser Permanente in Northern California without a change in surgical outcomes, according to research published today in the journal Obstetrics & Gynecology.
OHSU physicians and researchers are developing what they hope will be the first permanent total artificial heart, which could provide the approximately 75,000 Americans who die of heart failure every year another chance at life.
The medication tilarginine, a drug that was believed could be beneficial for patients who develop cardiogenic shock (low blood pressure due to impaired cardiac function) after a heart attack, did not reduce the risk of death up to six months after a heart attack, according to a JAMA study published online March 26.
Michigan State University scientists are engineering a virus-like particle, known as Qβ, that will generate anti-cancer immune responses in the body and potentially be used as a new vaccine for the treatment of cancer.
Eligible fully vaccinated passengers arriving in England from countries not on the UK's red list can take a cheaper lateral flow test instead of a PCR from today [Sunday 24 October].
› Verified 4 days ago
| Entity Name | Delnor Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407859655 PECOS PAC ID: 3971402371 Enrollment ID: O20040105000793 |
News Archive
A surgical procedure recommended to reduce the future risk of ovarian cancer has been successfully implemented throughout Kaiser Permanente in Northern California without a change in surgical outcomes, according to research published today in the journal Obstetrics & Gynecology.
OHSU physicians and researchers are developing what they hope will be the first permanent total artificial heart, which could provide the approximately 75,000 Americans who die of heart failure every year another chance at life.
The medication tilarginine, a drug that was believed could be beneficial for patients who develop cardiogenic shock (low blood pressure due to impaired cardiac function) after a heart attack, did not reduce the risk of death up to six months after a heart attack, according to a JAMA study published online March 26.
Michigan State University scientists are engineering a virus-like particle, known as Qβ, that will generate anti-cancer immune responses in the body and potentially be used as a new vaccine for the treatment of cancer.
Eligible fully vaccinated passengers arriving in England from countries not on the UK's red list can take a cheaper lateral flow test instead of a PCR from today [Sunday 24 October].
› Verified 4 days ago
| Entity Name | Central Dupage Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033149844 PECOS PAC ID: 5890696231 Enrollment ID: O20040303000601 |
News Archive
A surgical procedure recommended to reduce the future risk of ovarian cancer has been successfully implemented throughout Kaiser Permanente in Northern California without a change in surgical outcomes, according to research published today in the journal Obstetrics & Gynecology.
OHSU physicians and researchers are developing what they hope will be the first permanent total artificial heart, which could provide the approximately 75,000 Americans who die of heart failure every year another chance at life.
The medication tilarginine, a drug that was believed could be beneficial for patients who develop cardiogenic shock (low blood pressure due to impaired cardiac function) after a heart attack, did not reduce the risk of death up to six months after a heart attack, according to a JAMA study published online March 26.
Michigan State University scientists are engineering a virus-like particle, known as Qβ, that will generate anti-cancer immune responses in the body and potentially be used as a new vaccine for the treatment of cancer.
Eligible fully vaccinated passengers arriving in England from countries not on the UK's red list can take a cheaper lateral flow test instead of a PCR from today [Sunday 24 October].
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Stephen Nierzwicki, MD 25 N Winfield Rd, Winfield, IL 60190-1295 Ph: (630) 232-0280 | Dr Robert Stephen Nierzwicki, MD 25 N Winfield Rd, Winfield, IL 60190-1295 Ph: (630) 232-0280 |
News Archive
A surgical procedure recommended to reduce the future risk of ovarian cancer has been successfully implemented throughout Kaiser Permanente in Northern California without a change in surgical outcomes, according to research published today in the journal Obstetrics & Gynecology.
OHSU physicians and researchers are developing what they hope will be the first permanent total artificial heart, which could provide the approximately 75,000 Americans who die of heart failure every year another chance at life.
The medication tilarginine, a drug that was believed could be beneficial for patients who develop cardiogenic shock (low blood pressure due to impaired cardiac function) after a heart attack, did not reduce the risk of death up to six months after a heart attack, according to a JAMA study published online March 26.
Michigan State University scientists are engineering a virus-like particle, known as Qβ, that will generate anti-cancer immune responses in the body and potentially be used as a new vaccine for the treatment of cancer.
Eligible fully vaccinated passengers arriving in England from countries not on the UK's red list can take a cheaper lateral flow test instead of a PCR from today [Sunday 24 October].
› Verified 4 days ago
Georgios Christopoulos, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 500, Winfield, IL 60190 Phone: 630-232-0280 Fax: 630-315-1469 | |
Dr. Timothy J Mcgee, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd, Winfield, IL 60190 Phone: 630-690-4553 Fax: 630-690-2293 | |
Rutuja Desai Patel, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 520, Winfield, IL 60190 Phone: 630-938-8266 Fax: 630-933-7329 | |
Dane Eric Volden, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 400, Winfield, IL 60190 Phone: 630-456-7178 | |
Dr. Anjali Gera Gopal, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 432, Winfield, IL 60190 Phone: 630-933-4056 Fax: 630-933-5868 | |
Dr. Cody Braun, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 400, Winfield, IL 60190 Phone: 630-456-7178 Fax: 630-456-7486 | |
Margaret Eve Morrison, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 300, Winfield, IL 60190 Phone: 630-717-2600 Fax: 630-718-2656 |